Home  >  Products  >  MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)) Blocking Peptide (the N terminal of protein) (100ug)
MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)) Blocking Peptide (the N terminal of protein) (100ug)

MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MSH2 antibody (Catalogue #: ARP41351_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP41351
Size: 100 ug
Weight: 105kDa
Gene: 4436
Format: Lyophilized powder
Target: MSH2 was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. MSH2 was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: COCA1; FCC1; HNPCC; HNPCC1
See Full Product Listings >